Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 235.65M P/E - EPS this Y 30.00% Ern Qtrly Grth -
Income -496.98M Forward P/E -2.05 EPS next Y 80.20% 50D Avg Chg -13.00%
Sales - PEG - EPS past 5Y - 200D Avg Chg 24.00%
Dividend N/A Price/Book 0.19 EPS next 5Y - 52W High Chg -50.00%
Recommedations 2.70 Quick Ratio 7.44 Shares Outstanding 96.57M 52W Low Chg 149.00%
Insider Own 16.39% ROA -19.41% Shares Float 165.04M Beta -0.35
Inst Own 63.11% ROE -31.57% Shares Shorted/Prior 1.19M/554.38K Price 3.48
Gross Margin - Profit Margin - Avg. Volume 337,441 Target Price 10.58
Oper. Margin - Earnings Date Mar 11 Volume 84,017 Change -5.43%
About Gracell Biotechnologies Inc.

Gracell Biotechnologies Inc., a clinical-stage biopharmaceutical company, primarily discovers and develops cell therapies for the treatment of cancer in the People's Republic of China. Its lead product candidates include GC012F, a FasTCAR-enabled dual BCMA- and CD19-directed autologous CAR-T product candidate that is in Phase I trial for the treatment of multiple myeloma; GC019F, a FasTCAR-enabled CD19-directed autologous CAR-T product candidate, which is in Phase I clinical trial for the treatment of adult B cell acute lymphoblastic leukemia (B-ALL), as well as in phase 1 clinical trial for the treatment of relapsed or refractory (r/r) B cell acute lymphoblastic leukemia (B-ALL) in adult; and GC027, a TruUCAR-enabled CD7-directed allogeneic CAR-T product candidate, which is in Phase I clinical trial for the treatment of adult T cell acute lymphoblastic leukemia. The company's product candidates also comprise GC007g, a donor-derived CD19-directed allogeneic CAR-T cell therapy that is in Phase 2 clinical trial for the treatment of r/r B-ALL; and GC502, a TruUCAR-enabled dual CD19- and CD7 -directed, off-the-shelf allogeneic CAR-T product candidate, which is in Phase I trial for the treatment of B-cell malignancies. In addition, it has a portfolio of earlier stage product candidates targeting various cancer indications, such as hematologic cell malignancies and solid tumors. Gracell Biotechnologies Inc. was incorporated in 2017 and is headquartered in Suzhou, China. As of February 22, 2024, Gracell Biotechnologies Inc. operates as a subsidiary of AstraZeneca Treasury Limited.

GRCL Chatroom

User Image SDBiotechInvestor Posted - 04/26/24

$IMMX CAR-T NXC-201 late breaking, oral presentation two weeks out. Previous data has been perfection (100% ORR in AL Amyloidosis). Similar to $GRCL, these guys will likely get bought out in next 12-18 months if this kind of data keeps up.

User Image WallStreetBuyDip Posted - 04/25/24

I make this chart compliation of my previous trades to show why it's important to know H% is when making a trade. I only buy the dip for a reversal trade when its "H%" is low. These tickers are just one example of many plays. $GRCL are you the type to trade momentum or the type to buy the dip for a reversal trade? These only show 4 trades of 100+ others. Will trade GRCL like how I did for these tickers shown here.

User Image sunirg Posted - 7 months ago

@1LIFE2LIVE they already bought $GRCL so no chnace here

User Image Quantumup Posted - 7 months ago

Stifel⬆️ $CABA $32 was $31/Buy~believes if CABA-201 looks in-line w/ other CAR T's, invs will gain > comfort around the IASO-procured CAR T's /Co's ability2generate high efficacy data in US pts; thinks CABA's weak because Co hasn't yet Tx'd an SLE pt. Co is clearly making progress in Myositis, and per Stifel's convo w/ Mgmt/r confident that they will have SLE data by 1H24. $grcl $autl $bmy $kytx nvs

User Image Digital_Waffle_Pirate Posted - 8 months ago

$GRCL $KRON 🙏 thank you for the kind words - but keep scrolling tho, there’s some epic losers in there 🤣😂 After all, I’m just a breakfast food.

User Image StockAuthority Posted - 8 months ago

$KRON know who you trade with this guy is a baller caller wow! 4 bagger caller biotech $GRCL 2.52 to 10.22 BUYOUT and now he’s saying he wants an 8 bagger from here on $KRON I’m adding more tomorrow now that I’ve scrolled his profile and seen his picks 😮 💰 😮

User Image StockAuthority Posted - 8 months ago

$KRON this dude knows how to pick biotech winners he got a triple on this pick $GRCL and now he’s excited about another stock being slept on w only 540 watchers, ie $KRON

User Image LabPsycho Posted - 8 months ago

$KRON @Digital_Waffle_Pirate Excellent comparison $GRCL

User Image StockAuthority Posted - 8 months ago

$KRON is this the next $GRCL 2.0 that went up 650%??? Read the DD and decide for yourself!

User Image GuerillaStockTrading Posted - 02/25/24

Advancing Cell Therapy for Lupus Treatment: A Promising Frontier $RNAC $GRCL $KYTX https://www.guerillastocktrading.com/advancing-cell-therapy-for-lupus-treatment-a-promising-frontier/

User Image Ninja_Tradez Posted - 02/22/24

📢 $GRCL - Stifel Downgrades Gracell Biotechnologies to Hold, Lowers Price Target to $10.25 https://newsfilter.io/a/b44bbc4e88276819520a1f12d2519285

User Image Stock_Titan Posted - 02/22/24

$GRCL Gracell Biotechnologies Acquisition Completed https://www.stocktitan.net/news/GRCL/gracell-biotechnologies-acquisition-sxjlblaufwci.html

User Image tradethehalt Posted - 8 months ago

$GRCL trade halt (T12) was alerted to our Members at 7:50pm EST. Halt price: $10.25 Vol: 6.42M.

User Image HaltTradeAlert Posted - 8 months ago

$GRCL Halt Time: 19:50:00 Issue Symbol: GRCL Reason Code: T12 Stock Price: $10.25 Market Cap: 989.867M Volume: 6,373,187 Relative Volume: 4.61 Shares Float: 165.04M Get this alert real time and sent to your phone just like a text by going to our website and joining our community for FREE! We just launched this service! Help us spread the word ! www.HaltTradeAlert.com

User Image CTFNLighthouse Posted - 9 months ago

$GRCL $AZN Gracell Biotechnologies shareholders approved the company’s proposed acquisition by AstraZeneca. The transaction is expected to close on or around February 22.

User Image pepe7 Posted - 9 months ago

$GRCL

User Image Stock_Titan Posted - 9 months ago

$GRCL Gracell Biotechnologies Announces Shareholders’ Approval of Merger Agreement https://www.stocktitan.net/news/GRCL/gracell-biotechnologies-announces-shareholders-approval-of-merger-q6cd5rk333w8.html

User Image TeresaTrades Posted - 9 months ago

Largest PUT OI increases $KVUE $PSEC $WBD $GRCL $PINS

User Image TurboWago Posted - 9 months ago

$GRCL eyeing sept 20, 2024 $12.50 calls, if the buy out happens wouldn’t share price be higher then $12.50? Calls at $0.15 break even $12.65 and buyout was about a 20%+ premium?

User Image TalkMarkets Posted - 9 months ago

Week In Review: Shanghai Inmagene Signs $230 Million Deal To Develop Two HutchMed Immunology Assets $SNY $HCM $GRCL https://talkmarkets.com/content/global-markets/week-in-review-shanghai-inmagene-signs-230-million-deal-to-develop-two-hutchmed-immunology-assets?post=430414&userid=123969

User Image stang882 Posted - 01/30/24

$GRCL has anyone deciphered what we actually get if we just hold shares until after the merger is complete?

User Image DonCorleone77 Posted - 01/29/24

$GRCL 2 of 2 - Gracell announces FDA clearance of IND application for Phase 1 trial of GC012F ...."This IND marks an exciting milestone as we extend efforts to address significant unmet needs earlier in multiple myeloma treatment through GC012F's unique dual-targeting approach and FasTCAR manufacturing, which have already shown great promise for deeper, durable responses. It also clears the path toward generating safety and efficacy data specifically in ELMM patients, providing us with the opportunity to better explore and define GC012F's potential role across this initial treatment setting where there is a deep need to drive improved, sustained outcomes."

User Image DonCorleone77 Posted - 01/29/24

$GRCL 1 of 2 - Gracell announces FDA clearance of IND application for Phase 1 trial of GC012F Gracell Biotechnologies announced that the U.S. Food and Drug Administration, FDA, has cleared Gracell's Investigational New Drug, IND, application, allowing the Company to initiate a Phase 1 clinical trial of GC012F in the United States for the early-line treatment of multiple myeloma, ELMM. "We are extremely pleased to receive our third U.S. IND clearance for our lead FasTCAR candidate GC012F, now expanding company-sponsored investigation into early-line multiple myeloma," said Dr. William Cao, founder, Chairman and Chief Executive Officer of Gracell....

User Image WallStreetBuyDip Posted - 01/27/24

I only buy the dip for a reversal trade when its "H%" is low. These tickers are just one example of many plays. $GRCL are you the type to trade momentum or the type to buy the dip for a reversal trade? These only show 4 trades of 100+ others. Will trade GRCL like how I did for these tickers shown here.

User Image TeresaTrades Posted - 01/25/24

Heavy options volume $AMSC $IFF $ENTG $RC $GRCL

User Image InsiderFinance Posted - 01/24/24

🚨 Heavy institutional volume on $GRCL! Options trading 5.4x the daily average, ranking 3 on 🔥 INSIDERFINANCE.IO 🔥 Explore more ➡ @InsiderFinance. Snapshot: - Ticker: $GRCL - Momentum Rank: 3 - Volume Surge: 5.4x daily avg 👇 Dive into the options contracts and market analysis in the below screenshot from InsiderFinance's award-nominated trading toolkit.

User Image InsiderFinance Posted - 01/23/24

🚨 Heavy institutional volume on $GRCL! Options trading 5.4x the daily average, ranking 3 on 🔥 INSIDERFINANCE.IO 🔥 Explore more ➡ @InsiderFinance. Snapshot: - Ticker: $GRCL - Momentum Rank: 3 - Volume Surge: 5.4x daily avg 👇 Dive into the options contracts and market analysis in the below screenshot from InsiderFinance's award-nominated trading toolkit.

User Image WallStreetBuyDip Posted - 01/23/24

I only buy the dip for a reversal trade when its "H%" is low. These tickers are just one example of many plays. $GRCL are you the type to trade momentum or the type to buy the dip for a reversal trade? These only show 4 trades of 100+ others. Will trade GRCL like how I did for these tickers shown here.

User Image TrendyChart Posted - 01/22/24

$GRCL Technical patterns on the stock chart paint a picture of potential prosperity, with support levels bolstering its foundation. 🚀 https://thetrendychart.com/

User Image WallStreetBuyDip Posted - 10 months ago

I only buy the dip for a reversal trade when its "H%" is low. These tickers are just one example of many plays. $GRCL are you the type to trade momentum or the type to buy the dip for a reversal trade? These only show 4 trades of 100+ others. Will trade GRCL like how I did for these tickers shown here.